Zobrazeno 1 - 10
of 37
pro vyhledávání: '"HIVconsv"'
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1187 (2023)
We develop candidate HIV-1 vaccines, of which two components, ChAdOx1.tHIVconsv1 (C1) and ChAdOx1.HIVconsv62 (C62), are delivered by the simian adenovirus-derived vaccine vector ChAdOx1. Aberrant adenovirus RNA splicing involving transgene(s) coding
Externí odkaz:
https://doaj.org/article/d2c0d79c90a24a658608c65b279afae5
Autor:
Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, Christian Manzardo, Maria C. Puertas, Sara Morón-López, Anuska Llano, Cristina Miranda, Samandhy Cedeño, Miriam López, Yovaninna Alarcón-Soto, Guadalupe Gómez Melis, Klaus Langohr, Ana M. Barriocanal, Jessica Toro, Irene Ruiz, Cristina Rovira, Antonio Carrillo, Michael Meulbroek, Alison Crook, Edmund G. Wee, Jose M. Miró, Bonaventura Clotet, Marta Valle, Javier Martinez-Picado, Tomáš Hanke, Christian Brander, José Moltó, The BCN02 Study Investigators
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Kick&kill strategies combining drugs aiming to reactivate the viral reservoir with therapeutic vaccines to induce effective cytotoxic immune responses hold potential to achieve a functional cure for HIV-1 infection. Here, we report on an open-label,
Externí odkaz:
https://doaj.org/article/488e5500178f4b47bb1f5b03a865f708
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1187
We develop candidate HIV-1 vaccines, of which two components, ChAdOx1.tHIVconsv1 (C1) and ChAdOx1.HIVconsv62 (C62), are delivered by the simian adenovirus-derived vaccine vector ChAdOx1. Aberrant adenovirus RNA splicing involving transgene(s) coding
Autor:
Nathifa Moyo, Edmund G. Wee, Bette Korber, Kapil Bahl, Samantha Falcone, Sunny Himansu, Adrianne L. Wong, Antu K. Dey, Mark Feinberg, Tomáš Hanke
Publikováno v:
Vaccines, Vol 8, Iss 3, p 360 (2020)
A vaccine will likely be one of the key tools for ending the HIV-1/AIDS epidemic by preventing HIV-1 spread within uninfected populations and achieving a cure for people living with HIV-1. The currently prevailing view of the vaccine field is to intr
Externí odkaz:
https://doaj.org/article/c6a3f4acd94640fab6a5e393110fa76d
Autor:
Yehia S. Mohamed, Nicola J. Borthwick, Nathifa Moyo, Hayato Murakoshi, Tomohiro Akahoshi, Francesca Siliquini, Zara Hannoun, Alison Crook, Peter Hayes, Patricia E. Fast, Gaudensia Mutua, Walter Jaoko, Sandra Silva-Arrieta, Anuska Llano, Christian Brander, Masafumi Takiguchi, Tomáš Hanke
Publikováno v:
Vaccines, Vol 8, Iss 2, p 260 (2020)
Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8+ T cells are an important component of the host immune response to HIV-1 and may need
Externí odkaz:
https://doaj.org/article/153ce30639e44cfdbf69e802818a6554
Autor:
Nicola Borthwick, Sandra Silva-Arrieta, Anuska Llano, Masafumi Takiguchi, Christian Brander, Tomáš Hanke
Publikováno v:
Vaccines, Vol 8, Iss 1, p 28 (2020)
CD4+ T-cell responses play an important role in the immune control of the human immunodeficiency virus type 1 (HIV-1) infection and as such should be efficiently induced by vaccination. It follows that definition of HIV-1-derived peptides recognized
Externí odkaz:
https://doaj.org/article/7187e9bef71c4ab59beb9d55c075d499
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Muñoz Moreno, Jose Antonio, Carrillo Molina, Sara, Martínez Zalacaín, Ignacio, Miranda, Cristina, Manzardo, Christian, Coll, Pep, Meulbroek, Michael, Hanke, Tomáš, Garolera, Maite, Miró, Josep M., Brander, Christian, Clotet, Bonaventura, Soriano Mas, Carles, Moltó, José, Mothe, Beatriz, BCN02-Neuro Substudy Group
Publikováno v:
AIDS
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Objective: To assess the central nervous system (CNS) impact of a kick&kill HIV cure strategy using therapeutic vaccine MVA.HIVconsv and the histone deacetylase inhibitor (HDACi) romidepsin (RMD) as latency-reversing agent. Design: Neurological obser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f44d733191cb2b320346b9147fb543
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6973
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6973
Autor:
Yehia S, Mohamed, Nicola J, Borthwick, Nathifa, Moyo, Hayato, Murakoshi, Tomohiro, Akahoshi, Francesca, Siliquini, Zara, Hannoun, Alison, Crook, Peter, Hayes, Patricia E, Fast, Gaudensia, Mutua, Walter, Jaoko, Sandra, Silva-Arrieta, Anuska, Llano, Christian, Brander, Masafumi, Takiguchi, Tomáš, Hanke
Publikováno v:
Vaccines
Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8+ T cells are an important component of the host immune response to HIV-1 and may need
Autor:
Alison Crook, Nathifa Moyo, Hayato Murakoshi, Nicola Borthwick, Christian Brander, Tomáš Hanke, Walter Jaoko, Patricia E. Fast, Francesca Siliquini, Masafumi Takiguchi, Gaudensia Mutua, Peter Hayes, Yehia S. Mohamed, Tomohiro Akahoshi, Anuska Llano, Zara Hannoun, Sandra Silva-Arrieta
Publikováno v:
Vaccines
Volume 8
Issue 2
Vaccines, Vol 8, Iss 260, p 260 (2020)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Volume 8
Issue 2
Vaccines, Vol 8, Iss 260, p 260 (2020)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8+ T cells are an important component of the host immune response to HIV-1 and may need